WayneNLeimbachMD
Cardiology • Tulsa, OKAdult Congenital Heart Disease, Interventional Cardiology
Associate Clinical Professor of Medicine, University Okla College of Medicine
Are you Dr. Leimbach?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 95 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1265 S Utica Ave
Suite 300
Tulsa, OK 74104Phone+1 918-592-0999Fax+1 918-592-1021
Summary
- Dr. Wayne Leimbach, MD is a cardiologist in Tulsa, Oklahoma. He is currently licensed to practice medicine in Oklahoma and Iowa. He is affiliated with Hillcrest Medical Center and is an Associate Clinical Professor of Medicine at University Okla College of Medicine.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Cardiovascular Disease, 1982 - 1985- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1979 - 1982
Northwestern University The Feinberg School of MedicineClass of 1979
Certifications & Licensure
OK State Medical License 1986 - 2025
IA State Medical License 1979 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- National Board of Physicians and Surgeons Cardiovascular Disease
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 1 citationsThe CLOSER trial: a multi-center study on the clinical safety and effectiveness of closer(TM) VSS, a novel resorbable transfemoral vascular access sealing system.S. Chiu Wong, Roger Gammon, William Bachinsky, Charles O'Shaughnessy, Wayne Leimbach
Catheterization and Cardiovascular Interventions. 2017-08-23
Press Mentions
Oklahoma Heart Institute Implants First-of-Its-Kind Naturally Dissolving Heart Stent in Patient with Coronary Artery DiseaseAugust 26th, 2016
Professional Memberships
- Member
- Member
